New precision therapy aims to help tiniest babies with heart problem
NCT ID NCT07374146
First seen Feb 01, 2026 · Last updated May 21, 2026 · Updated 13 times
Summary
This study focuses on extremely preterm infants (born before 32 weeks) who have a heart condition called hsPDA, where a blood vessel fails to close after birth. Researchers will collect blood samples and health data to create a model that predicts which babies are at highest risk. They are also developing a targeted drug-delivery system to treat the condition more precisely and safely. The goal is to improve treatment by personalizing it for each infant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.